ArticleTechniques in coloproctology2022
Sinus laser-assisted closure (SiLaC®) for pilonidal disease: results of a multicentre cohort study.
Article in Techniques in coloproctology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)
Radiofrequency Treatment for Pilonidal Disease : Clinical Investigation on Safety of Use, Efficacy and Patient Satisfaction at 6 Months
Who cites it
18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.
- A systematic review and meta-analysis of sinus laser associated closure (SiLaC) versus endoscopic pilonidal sinus treatment (EPSiT) in the management of pilonidal sinus disease.Langenbeck's archives of surgery · 2026Pooled it
- International Society of Laser Proctology Position Paper on SiLaC and EPSiT/SiLaC in the Management of Pilonidal Sinus Disease.Lasers in surgery and medicine · 2025Guideline
- Efficacy and safety of laser ablation for recurrent pilonidal sinus: a systematic review and meta‑analysis.International journal of colorectal disease · 2025Pooled it
- Non-excisional techniques for the treatment of intergluteal pilonidal sinus disease: a systematic review.Techniques in coloproctology · 2023Pooled it
- Is it beneficial to add laser ablation to curettage in the treatment of pilonidal sinus disease?Lasers in medical science · 2025Trial
- Necrotising Fasciitis Following Sinus Laser-Assisted Closure Treatment for Pilonidal Disease: A Case Report.Cureus · 2026Article
- Early postoperative outcomes of sinus laser closure versus crystallized phenol treatment for pilonidal sinus disease: a retrospective comparative study.Techniques in coloproctology · 2026Article
- Sinus laser-assisted closure (SiLaC) in pilonidal sinus disease: a multicenter cohort study.Techniques in coloproctology · 2026Article
- Radiofrequency for the treatment of pilonidal disease: results of a French prospective pilot study.Annals of coloproctology · 2026Article
- The New Minimally Invasive Techniques for Pilonidal Sinus Disease Surgery: Choosing the Right Technique for the Right Patient-A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
- Exploratory pilot study of minimally invasive therapy: laser ablation combined with acellular dermal matrix implantation for recurrent sacrococcygeal pilonidal disease.Frontiers in bioengineering and biotechnology · 2026Article
- Future of pilonidal cyst surgery: a comparative review of traditional and laser techniques.BMC surgery · 2025Review
- Evaluation of laser ablation for recurrent pilonidal sinus disease: treatment success, recurrence rates, and patient outcomes.Lasers in medical science · 2025Article
- Long-term follow-up of pilonidal sinus disease treated by radial laser surgery.Langenbeck's archives of surgery · 2024Article
- Short- and mid-term results of diode laser treatment in pilonidal sinus disease and the role of endoscopic camera use on outcomes.Techniques in coloproctology · 2023Article
- Laser ablation: a unique and beneficial therapeutic option for pilonidal sinus? And the potential for further innovation-a review.Lasers in medical science · 2023Review
- An effective and considerable treatment of pilonidal sinus disease by laser ablation.Lasers in medical science · 2023Article
- Does minimally invasive laser-assisted treatment of pilonidal sinus disease live up to its expectations: a multi-center study with 226 patients.International journal of colorectal disease · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn emerging and promising minimally invasive treatment for pilonidal disease (PD) is sinus laser-assisted closure (SiLaC®). Previous studies have shown encouraging results concerning safety, patient satisfaction, wound healing and acceptable recurrence rates. This study investigated outcomes for a large cohort of PD patients treated with SiLaC®.
methodsA multicentre cohort study with a prospective design and partial retrospective data collection for patients with PD treated with SiLaC® in three hospitals in the Netherlands (Albert Schweitzer Hospital, Flevoziekenhuis and Medical Centre Zuiderzee) from January 1st 2017 to March 1st 2020. The primary outcome was recurrence. Secondary outcomes were incidence of complete wound closure, time until wound closure, postoperative complications, ability to perform daily activities and reported patient satisfaction.
resultsA total of 311 patients were included with a median follow-up of 10 months (range 1-52 months). The recurrence rate after one SiLaC® treatment was 26% with 7% experiencing incomplete wound closure, resulting in an initial success rate of 66% after one SiLaC® procedure. This increased to 92% and 98% after two and three SiLaC® procedures, respectively. Mean time until wound closure was 6 weeks (range 1-24 weeks). Seven patients (2%) were still unsuccessfully treated after three SiLaC® treatments and required additional and extensive surgery. Mean time to perform regular daily activities including working was 6 days (range 0-42 days) and the vast majority of patients (84%) did not require painkillers or only paracetamol. Twelve patients (4%) developed a postoperative wound infection. The mean satisfaction score was 9 (range 5-10).
conclusionsSiLaC® is a promising minimally invasive treatment for PD with high patient satisfaction and an acceptable success rate. These results suggest that SiLaC® could be used as a safe and effective primary treatment for PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.